A pooled health-economic analysis of DAPA-HF and DELIVER: A French cost-effectiveness analysis of dapagliflozin for the treatment of patients with heart failure
22 May 2023 (12:00 - 12:30)
Organised by: 
Abstract
Slides
About the speaker
AstraZeneca BioPharmaceuticals, Gaithersburg (United States of America)
3 More presentations in this session
Doctor S. Urban (Lubin, PL)
Professor M. Rothman (Irvine, US)
Access the full session
The Event
Heart Failure 2023
22 May 2023
12:00 CET
You may be interested in
Congress Presentation
Congress Session
